Israel Primary Biliary Cholangitis Market (2025-2031) | Industry, Competitive Landscape, Analysis, Value, Segmentation, Outlook, Growth, Share, Size & Revenue, Forecast, Companies, Trends

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Israel Country Macro Economic Indicators

3.2 Israel Primary Biliary Cholangitis Market Revenues & Volume, 2021 & 2031F

3.3 Israel Primary Biliary Cholangitis Market - Industry Life Cycle

3.4 Israel Primary Biliary Cholangitis Market - Porter's Five Forces

3.5 Israel Primary Biliary Cholangitis Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F

3.6 Israel Primary Biliary Cholangitis Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F

3.7 Israel Primary Biliary Cholangitis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.8 Israel Primary Biliary Cholangitis Market Revenues & Volume Share, By End-Users, 2021 & 2031F

3.9 Israel Primary Biliary Cholangitis Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of primary biliary cholangitis in Israel

4.2.2 Rising awareness about early diagnosis and treatment options

4.2.3 Technological advancements in diagnostic tools and treatment modalities

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for drug approval

4.3.2 Limited availability of specialized healthcare professionals

4.3.3 High treatment costs for primary biliary cholangitis therapies

6.1 Israel Primary Biliary Cholangitis Market, By Treatment Type

6.1.1 Overview and Analysis

6.1.2 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Treatment Type, 2021- 2031F

6.1.3 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Liver Transplantation, 2021- 2031F

6.1.4 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Drug Therapy, 2021- 2031F

6.1.5 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Ursodeoxycholic acid (UDCA), 2021- 2031F

6.1.6 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Obeticholic acid, 2021- 2031F

6.1.7 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Fibrates, 2021- 2031F

6.1.8 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Budesonide, 2021- 2031F

6.2 Israel Primary Biliary Cholangitis Market, By Diagnosis

6.2.1 Overview and Analysis

6.2.2 Israel Primary Biliary Cholangitis Market Revenues & Volume, By FibroScan, 2021- 2031F

6.2.3 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Blood Tests, 2021- 2031F

6.2.4 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Cholesterol Test, 2021- 2031F

6.2.5 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Antibody Test, 2021- 2031F

6.2.6 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Liver Test, 2021- 2031F

6.2.7 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Others, 2021- 2031F

6.3 Israel Primary Biliary Cholangitis Market, By Route of Administration

6.3.1 Overview and Analysis

6.3.2 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Oral, 2021- 2031F

6.3.3 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Parenteral, 2021- 2031F

6.3.4 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Others, 2021- 2031F

6.4 Israel Primary Biliary Cholangitis Market, By End-Users

6.4.1 Overview and Analysis

6.4.2 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Hospitals, 2021- 2031F

6.4.3 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Specialty Clinics, 2021- 2031F

6.4.4 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Homecare, 2021- 2031F

6.4.5 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Others, 2021- 2031F

6.5 Israel Primary Biliary Cholangitis Market, By Distribution Channel

6.5.1 Overview and Analysis

6.5.2 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.5.3 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

6.5.4 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Online Pharmacy, 2021- 2031F

6.5.5 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Others, 2021- 2031F

7.1 Israel Primary Biliary Cholangitis Market Export to Major Countries

7.2 Israel Primary Biliary Cholangitis Market Imports from Major Countries

8.1 Average time to diagnosis for primary biliary cholangitis patients

8.2 Adoption rate of novel treatment options in the market

8.3 Number of clinical trials focused on primary biliary cholangitis treatments

8.4 Patient adherence rate to prescribed treatment regimens

8.5 Rate of hospital readmissions for primary biliary cholangitis patients

9.1 Israel Primary Biliary Cholangitis Market Opportunity Assessment, By Treatment Type, 2021 & 2031F

9.2 Israel Primary Biliary Cholangitis Market Opportunity Assessment, By Diagnosis, 2021 & 2031F

9.3 Israel Primary Biliary Cholangitis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.4 Israel Primary Biliary Cholangitis Market Opportunity Assessment, By End-Users, 2021 & 2031F

9.5 Israel Primary Biliary Cholangitis Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10.1 Israel Primary Biliary Cholangitis Market Revenue Share, By Companies, 2024

10.2 Israel Primary Biliary Cholangitis Market Competitive Benchmarking, By Operating and Technical Parameters